According to available medical research, Calcium has been found to play a beneficial role in preventing and helping with certain types of liver diseases. One such liver condition is non-alcoholic fatty Liver disease (NAFLD), which is characterized by the accumulation of excessive fat in the liver. Studies have suggested that Calcium supplementation may help reduce liver fat, inflammation, and fibrosis associated with NAFLD. Calcium's ability to regulate lipid metabolism, oxidative stress, and inflammation within liver cells could contribute to its beneficial effects.
Moreover, Calcium has also been shown to have a protective effect against liver cancer. Research indicates that adequate Calcium intake may lower the risk of developing hepatocellular carcinoma, the most common type of liver cancer. By potentially inhibiting cell proliferation and promoting apoptosis (programmed cell death) in liver cancer cells, Calcium may impede tumor growth. However, further studies are still required to elucidate the exact mechanisms through which Calcium exerts these protective effects and to identify the optimal dosage for Liver disease prevention and management.
![SUPPLEMENT FACTS
Serving Size 2 Capsule
Servings Per Container 60
—
Amount Per Serving
Sulforaphane Glucosinolate 35 mg T
(from Broccoli Seed Extract [Brass/ca o/eracea L.
Ital/ca] [Standardized to 3.5% SGS] in a Proprietary
Blend Containing Myrosinase Enzyme)
—
1' Daily Value (DV) not established.
Other Ingredients: Delayed-release veggie capsule (hydroxypropylmethylcellulose,
water), maltodextrin and calcium ascorbate.
MILLIGRAMS
SULFORAPHANE
GLUCOSINOLATE
DELAYED RELEASE
VEGGIE CAPS](https://m.media-amazon.com/images/I/71-yuAwiWBL._AC_SL1500_.jpg)
